Datar Cancer Genetics signs US $ 250 million contract with Artemis DNA
Under the 5-year exclusive agreement, Artemis DNA will provide Datar's pioneering cancer detection Liquid Biopsies in the USA and Vietnam markets
Under the 5-year exclusive agreement, Artemis DNA will provide Datar's pioneering cancer detection Liquid Biopsies in the USA and Vietnam markets
SCG101 is an autologous T-cell receptor (TCR) T-cell therapy for liver cancer
He was previously working as the CEO of IVD business at Trivitron Healthcare and drove its growth through innovation
In the UK, Bartec has been synonymous with Mediso products for 18 years, proof of a successful partnership
The facility is among 12 centres established worldwide, and the first in Asia
The inspection was triggered by Shilpa's submission of applications for four ANDA's to seek approval to use this site as an alternate testing laboratory
Pharma exports in 2021-22 sustain a positive growth despite global trade disruptions
First approved therapy in Europe for the treatment of chronic kidney disease (CKD)-associated pruritus in hemodialysis patients
The round also saw participation from US-based fund 57 Stars, a few prominent angel investors, existing investors Stellaris Venture Partners, Vertex Ventures, and Alteria Capital
Revolution Aspire CT System is manufactured at the company’s new plant launched under the government’s Production Linked Incentives (PLI) Scheme
Subscribe To Our Newsletter & Stay Updated